OC
TMO icon

Optimas Capital’s Thermo Fisher Scientific TMO Stock Holding History

Optimas Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,400
Closed -$3M – 39
2025
Q2 		$3M Buy
+7,400
New +$3.09M 3.16% 12
2024
Q1 		– Sell
-5,386
Closed -$2.86M – 52
2023
Q4 		$2.86M Buy
+5,386
New +$2.61M 2.7% 13
2023
Q1 		– Sell
-11,964
Closed -$6.59M – 46
2022
Q4 		$6.59M Buy
11,964
+1,185
+11% +$628K 6.45% 5
2022
Q3 		$5.47M Buy
10,779
+979
+10% +$548K 4.61% 8
2022
Q2 		$5.32M Sell
9,800
-4,679
-32% -$2.58M 6.53% 4
2022
Q1 		$8.55M Buy
14,479
+9,900
+216% +$5.69M 8.03% 3
2021
Q4 		$3.06M Buy
+4,579
New +$2.86M 6.53% 5

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Optimas Capital's TMO Position: Q3 2025 in Review

Optimas Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 7,400 shares — an estimated $3M sold.

Optimas Capital first reported a position in TMO in Q4 2021 and held it in 7 quarters. The position peaked at $8.55M in Q1 2022. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Optimas Capital reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Optimas Capital sold 7,400 Thermo Fisher Scientific shares in Q3 2025, an estimated $3M.
  • Optimas Capital first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 7 quarters.
  • Optimas Capital's Thermo Fisher Scientific position peaked at $8.55M in Q1 2022.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Optimas Capital's 13F filing for Q3 2025, filed 6 Nov 2025.